Stanley-Laman Group, Ltd.

SEC CIK: 0001601489
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Stanley-Laman Group, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overview All 13F holders of AXSM Full Q2 2026 holdings

Shares (Q2 2026): 19,170
Value: $4.69M
% of portfolio: 0.5%
Quarters held: 4; Since Q3 2025

Holdings of AXSM by Stanley-Laman Group, Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	19,170	$4.69M	0.5%	−90−0.5%	Reduced	Holders
Q1 2026	19,260	$3.26M	0.4%	+1,342+7.5%	Added	Holders
Q4 2025	17,918	$3.27M	0.4%	+417+2.4%	Added	Holders
Q3 2025	17,501	$2.13M	0.3%	+17,501	New	Holders